Treatment partners and adherence to Haart in Central Mozambique
Bibliographic Data
| ID | 19442155 |
|---|---|
| Authors | Benjamin A Stubbs (University of Washington Applied Physics Laboratory, corresponding author), Mark A Micek (University of Washington), J Pfeiffer (0000-0002-7985-9437, University of Washington), J T Pfeiffer (b Health Services , University of Washington , Seattle , WA , USA), Pablo Montoya (0000-0002-8415-3367, University of Washington), Stephen Gloyd (0000-0001-7017-8750, University of Washington) |
| Year | 2009 |
| Volume | 21 |
| Issue | 11 |
| Pages | 1412-1419 |
| Publication date | 2009-11-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | AIDS Care (JOURNAL) |
| Journal identifiers | ISSN: 0954-0121 • E-ISSN: 1360-0451 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/09540120902814395 |
| PMID | 20024718 |
| OpenAlex | W2093471634 |
| Language | EN |
| Citations received | 6 |
| References cited | 22 |
Adherence to highly active antiretroviral treatment (HAART) has been associated with increased survival rates and decreased drug resistance in various settings. There is growing concern that loss to follow-up will increase and adherence rates will decrease as HAART programs are expanded in resource-limited settings. In Central Mozambique, an innovative program was implemented, using community-based (trained community activists) and self-selected (family members or friends) "treatment partners" to provide psycho-social support to patients on HAART. We calculated adherence rates based on pharmacy records for all patients who refilled their medication for at least six consecutive months between September 2004 and June 2006. Medical charts were reviewed for a subset of 375 patients having high (> or =90%) adherence and 59 patients having low (<90%) adherence. Multivariate logistic regression analysis assessed the association between the type of treatment partner used and adherence to HAART. A total of 305 patients (70%) had self-selected treatment partners, 121 (28%) had community-based treatment partners, and 8 (2%) had no treatment partner. In adjusted analysis, patients who had no treatment partner were more likely to have low adherence (OR 9.47; 95% confidence interval 2.37-37.86 compared to self-selected treatment partner). Patients with community-based treatment partners did not have significantly lower adherence than patients with self-selected treatment partners. While it cannot be determined from these data which aspects or types of peer support are most effective in maintaining adherence, it appears that peer support was beneficial to this study population. While the study results are not directly applicable to other populations, other HAART programs should consider the potential benefit of providing treatment support to patients
Confidence interval · Environmental health · Family medicine · Logistic regression · Medical record · Multivariate analysis · Peer support · Population · Psychiatry · Social support · Demography · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Psychology · Internal Medicine · Pharmacy
Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa
Are treatment supporters relevant in long-term Antiretroviral Therapy (ART) adherence? Experiences from a long-term ART cohort in Uganda
Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda
The Impact of Community Support Initiatives on the Stigma Experienced by People Living with HIV/Aids in South Africa
Adherence to antiretroviral therapy and its determinants in children with HIV infection – Experience from Paediatric Centre of Excellence in HIV Care in North India
"Wan Kanyakla" (We are together)
Practical and Conceptual Challenges in Measuring Antiretroviral Adherence
Social Support, Positive States of Mind, and HIV Treatment Adherence in Men and Women Living With HIV/Aids.
Patient adherence to HIV medication regimens
Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
Factors Affecting Adherence to Antiretroviral Therapy
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America
Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy.
Adherence to Haart among patients with HIV
Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil
A General Method of Compliance Assessment Using Centralized Pharmacy Records
| Unique citing works | 6 |
|---|---|
| Citations per year | 0.5 |
| Citation span | 2014 - 2018 (5) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 6 |